United States
Germany
Japan
United Kingdom
China
Recombinant Anti-Tim-4 (Clone 5G3)
| Applications | Bl, ELISA, FC, IF, IHC, WB |
| Reactivities | Mouse |
Antibodies
Recombinant Anti-Mesothelin (Clone IC14-30)
| Applications | ELISA |
| Reactivities | Human |
Recombinant Anti-PRMT5 (Clone RAB-C136)
| Applications | ChIP, ELISA, IF |
| Reactivities | Human |
Recombinant Anti-CBX2 (Clone RAB-C238)
| Applications | ChIP, ELISA, IF |
| Reactivities | Human |
Recombinant Anti-PRDM9 (Clone RAB-C370)
| Applications | ChIP, ELISA, IF |
| Reactivities | Human |
Recombinant Anti-EGFR (Clone 2F8 (Zalutumumab; HuMax-EGFR))
| Applications | ELISA, FC, WB |
| Reactivities | Human |
Recombinant Anti-CD81 (Clone 1D6)
| Applications | ELISA, FC, IF, IHC, IP, WB |
| Reactivities | Human, Chimpanzee, Goat, Sheep |
Recombinant Anti-IL2R (Clone AHT54)
| Applications | Bl, ELISA, FC |
| Reactivities | Human |
Recombinant Anti-DARC (Clone 2C3)
| Applications | Bl, ELISA, FC |
| Reactivities | Human |
Recombinant Anti-C5aR (Clone S5/1)
| Applications | Bl, ELISA, FC, FN, IP, WB |
| Reactivities | Human, Rabbit, Cow, Ferret |
Recombinant Anti-Tetraspanin 1 (Clone 4/12)
| Applications | ELISA, IF, IHC |
| Reactivities | Human |
Recombinant Anti-Discoidin Domain Receptor 1 (Clone 3E3)
| Applications | Bl, ELISA, WB |
| Reactivities | Human |
Recombinant Anti-SNCG (Clone SAIC-31A-10)
| Applications | ELISA, WB |
| Reactivities | Human |
Recombinant Anti-UBE2I (Clone SAIC-36A-9)
| Applications | ELISA, WB |
| Reactivities | Human |
Recombinant Anti-ERBB2 (Clone SAIC-02A-7)
| Applications | ELISA, WB |
| Reactivities | Human |
活动过滤器
优化搜索结果
Target Symbol
- CCR5 (4)
- MSLN (4)
- CD44 (3)
- EGFR (3)
- MUC1 (3)
- TNF (3)
- AOC3 (2)
- CCRL2 (2)
- CD28 (2)
- CD4 (2)
- CD52 (2)
- CTLA4 (2)
- ERBB2 (2)
- FN1 (2)
- GPC3 (2)
- HIS (2)
- IL2RA (2)
- IL9 (2)
- INSR (2)
- ITGB2 (2)
- N (2)
- NOTCH2 (2)
- PRDX4 (2)
- PXN (2)
- TIMD4 (2)
- TNFRSF8 (2)
- V5 (2)
- VEGFA (2)
- XPNPEP1 (2)
- ACKR1 (1)
- ACTA1 (1)
- ADRB2 (1)
- AGER (1)
- ANO1 (1)
- ANXA4 (1)
- APP (1)
- BETVI (1)
- BRD4 (1)
- BSG (1)
- C3AR1 (1)
- C5AR1 (1)
- CALR (1)
- CBX1 (1)
- CBX2 (1)
- CBX5 (1)
- CD1A (1)
- CD3E (1)
- CD40 (1)
- CD40LG (1)
- CD74 (1)
- CD81 (1)
- CDH1 (1)
- CDH17 (1)
- CDX2 (1)
- CENPE (1)
- CHRNB2 (1)
- CLU (1)
- CMKLR1 (1)
- COX1 (1)
- CR1 (1)
- CXCL8 (1)
- DDK (FLAG) (1)
- DDR1 (1)
- DES (1)
- DNTT (1)
- DSRNA (1)
- EDAR (1)
- EPCAM (1)
- EPHA2 (1)
- ESR1 (1)
- F (1)
- FAS (1)
- FCAR (1)
- FCGR2A (1)
- FGA (1)
- FGB (1)
- FOLH1 (1)
- FOXP1 (1)
- FOXP2 (1)
- FOXP4 (1)
- G1 (1)
- GFAP (1)
- GM2 (1)
- GROUP ANTIGEN (1)
- GYPA (1)
- H3 (1)
- H4 (1)
- HAEMOGLOBIN (1)
- HAVCR2 (1)
- HNF1B (1)
- IFNG (1)
- IGE (1)
- IGM (1)
- IL10 (1)
- IL16 (1)
- IL17A (1)
- IL18 (1)
- IL2 (1)
- IL4 (1)
- IL5 (1)
Reactivities
- Human (172)
- Mouse (30)
- Rat (12)
- Monkey (8)
- Rabbit (6)
- Bovine (3)
- Cow (3)
- Sheep (3)
- Chicken (2)
- Dog (2)
- Feline (2)
- Goat (2)
- Guinea Pig (2)
- His tag (2)
- Pig (2)
- Primate (2)
- SARS-CoV (2)
- V5 tag (2)
- Chimpanzee (1)
- Cynomolgus (1)
- DDK (FLAG tag): DYKDDDDK (1)
- Dengue virus (1)
- Ferret (1)
- Hamster (1)
- MAP tag (1)
- Respiratory Syncytial Virus (1)
- Virus (1)
- West Nile Virus (1)
- Yellow Fever Virus (1)
- Zebrafish (1)
Antibody Hosts
Conjugates
Modifications
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format for improved compatibility with existing reagents assays and techniques. (19)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format for improved compatibility with existing reagents assays and techniques. (7)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format for improved compatibility with existing reagents assays and techniques. (6)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format for improved compatibility with existing reagents assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgM format for improved compatibility with existing reagents assays and techniques. (1)
